(VIANEWS) – Shares of Inovio Pharmaceuticals (INO) rose by a staggering 10.94% to $9.49 at 12:17 EST on Thursday, after two consecutive sessions in a row of losses. NASDAQ Composite is jumping 0.12% to $14,782.93, after two consecutive sessions in a row of losses. This seems, up until now, a somewhat positive trend exchanging session today.
Inovio Pharmaceuticals’s last close was $8.55, 55% below its 52-week high of $19.00.
Today’s last reported volume for Inovio Pharmaceuticals is 10984127 which is 117.34% above its average volume of 5053804.
Inovio Pharmaceuticals’s Sales
Inovio Pharmaceuticals’s sales growth is 353.2% for the current quarter and 4688.1% for the next. The company’s growth estimates for the ongoing quarter is 69.9% and a drop 309.1% for the next.
Inovio Pharmaceuticals’s Revenue
Year-on-year quarterly revenue growth declined by 72%, now sitting on 6.46M for the twelve trailing months.
Inovio Pharmaceuticals’s last week, last month’s, and last quarter’s current volatility was a positive 0.08%, a negative 0.44%, and a positive 2.96%, respectively.
Inovio Pharmaceuticals’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.89% (last week), 2.92% (last month), and 2.96% (last quarter), respectively.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
Inovio Pharmaceuticals’s stock is considered to be overbought (>=80).
Inovio Pharmaceuticals’s Stock Yearly Top and Bottom Value
Inovio Pharmaceuticals’s stock is valued at $9.49 at 12:17 EST, way under its 52-week high of $19.00 and way higher than its 52-week low of $5.81.
Inovio Pharmaceuticals’s Moving Average
Inovio Pharmaceuticals’s worth is above its 50-day moving average of $8.68 and above its 200-day moving average of $9.29.
More news about Inovio Pharmaceuticals (INO).